Collectively, the results of the animal experiments validated the presence of hyperglycaemia-induced FOXD1-BCL-2 regulation and the beneficial effects of TBFs on hyperglycaemic injury through the regulation of this signalling axis. The gene discussed is FOXD1; the disease is Hyperglycemia.